The Current Ratio as of December 2025 (TTM) for Eris Lifesciences Limited (ERIS.NS) is 0.91

According to Eris Lifesciences Limited’s latest financial reports and current stock price. The company's current Current Ratio is 0.91. This represents a change of 103.13% compared to the average of 0.45 of the last 4 quarters.

Eris Lifesciences Limited (ERIS.NS) Historical Current Ratio (quarterly & annually)

How has ERIS.NS Current Ratio performed in the past?

The mean historical Current Ratio of Eris Lifesciences Limited over the last ten years is 2.30. The current 0.91 Current Ratio has changed 3.87% with respect to the historical average. Over the past ten years (40 quarters), ERIS.NS's Current Ratio was at its highest in in the March 2017 quarter at 5.07. The Current Ratio was at its lowest in in the January 2016 quarter at 0.

Eris Lifesciences Limited (ERIS.NS) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Eris Lifesciences Limited Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Eris Lifesciences Limited (ERIS.NS) Average Current Ratio

How has ERIS.NS Current Ratio performed in the past?

The current Current Ratio of Eris Lifesciences Limited (ERIS.NS) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Eris Lifesciences Limited (ERIS.NS) Current Ratio vs. Peers

How is ERIS.NS’s Current Ratio compared to its peers?

Eris Lifesciences Limited’s Current Ratio is less than Neuland Laboratories Limited (1.96), less than Neuland Laboratories Limited (1.96), less than Alembic Pharmaceuticals Limited (1.59), less than Jubilant Pharmova Limited (1.66), less than Jubilant Pharmova Limited (1.66), less than Alembic Pharmaceuticals Limited (1.59), greater than Piramal Enterprises Limited (0), less than Wockhardt Limited (1.56), less than Wockhardt Limited (1.56), less than AstraZeneca Pharma India Limited (1.87),

Build a custom stock screener for Eris Lifesciences Limited (ERIS.NS) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Eris Lifesciences Limited using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Eris Lifesciences Limited (ERIS.NS) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Eris Lifesciences Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.